Managing multiple myeloma during COVID-19: an ongoing saga
- 22 February 2021
- journal article
- editorial
- Published by Taylor & Francis Ltd in Postgraduate Medicine
- Vol. 133 (6), 589-591
- https://doi.org/10.1080/00325481.2021.1885882
Abstract
“The show must go on”Proverbial—initially applied to the United States 1876 centennial celebrations and originally printed in The Morning Republican (Scranton, PA) on 13 December 1875.No other time...Keywords
Funding Information
- No funding
This publication has 15 references indexed in Scilit:
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- Impact of the COVID-19 Outbreak on the Management of Patients with CancerTargeted Oncology, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumabBlood Advances, 2020
- Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive CardiologyAmerican Journal of Preventive Cardiology, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- Current status of autologous stem cell transplantation for multiple myelomaBlood Cancer Journal, 2019
- Global Burden of Multiple MyelomaJAMA Oncology, 2018
- Multiple myeloma epidemiology and survival: A unique malignancySeminars in Oncology, 2016
- Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patientsHaematologica, 2014